Preparation of PHEMA/nHAP nanocomposites via in situ polymerization in supercritical carbon dioxide for biomedical applications

Poly(2-hydroxyethylmethacrylate) (PHEMA)/hydroxyapatite (HAP) nanocomposites were synthesized through a new route involving nano-sized HAP (nHAP) particles or modified nHAP mixed with monomer 2-hydroxyethylmethacrylate via in situ polymerization in supercritical carbon dioxide (scCO 2 ). Fourier-transform infrared spectroscopy showed phosphate peak increased with nHAP content in composite. X-ray diffraction patterns of PHEMA/nHAP revealed the presence of crystallized nHAP. Thermogravimetric analysis showed that the ultimate nHAP content in PHEMA/nHAP composites is consistent with its initial amount. Scanning electron microscopy revealed that nanocomposite particles are much smaller than PHEMA particles. PHEMA/nHAP composites with average diameter of approximately 600 nm were obtained in scCO 2 with 94 % yield. Mechanical properties of PHEMA/nHAP nanocomposites were better than those of PHEMA, and compressive modulus and strength of composites with 30 wt.% nHAP were 193 and 29 MPa, respectively. Nanocomposite adsorption toward bovine serum albumin was evaluated, and results indicated that analyte adsorption amount can reach up to 282 mg/g.